Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited due to allegations of securities law violations, encouraging affected investors to come forward before the April 6, 2026 deadline for lead plaintiff applications [2][4]. Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives made false and misleading statements, failing to disclose involvement in a fraudulent stock promotion scheme and the use of offshore accounts for share dumping [4]. - Specific allegations include the omission of information regarding false rumors and artificial trading activity that inflated the stock price, leading to materially misleading public statements about the company's business and prospects [4]. Group 2: Stock Performance - Pomdoctor's stock experienced a significant decline, dropping from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, marking a decline of roughly 24% in a single trading session [5]. - This decline was attributed to heightened volatility and selling pressure amid investor concerns regarding the company's financial performance and valuation [5]. Group 3: Legal Proceedings - The firm is reminding investors of the April 6, 2026 deadline to seek the role of lead plaintiff in the federal securities class action against Pomdoctor [2]. - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member, with no impact on their ability to share in any recovery [6]. Group 4: Firm Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. - The firm has offices in New York, Pennsylvania, California, and Georgia, and encourages anyone with information regarding Pomdoctor's conduct to contact them [3][7].
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pomdoctor